Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

persistent failure of HIV treatment, or opportunistic infection, the adjusted hazard ratio was an even 1.00, representing non-inferiority, with no significant differences in the composite outcomes ...

Gilead Sciences Inc. (GILD) and Merck & Co Inc.(MRK) announced new results from a Phase 2 clinical study evaluating the ...

A new study found people with HIV can safely receive donated kidneys from deceased donors with the virus. In the study ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Keep reading to find out the key distinctions between HIV and AIDS, including symptoms, progression, treatment options, and overall impact on health. Are HIV and AIDS the Same Thing? HIV and AIDS ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

The act of feeding a baby with breast milk, known as breastfeeding, not only provides the baby with perfect nutrition but also helps the baby fight off many illnesses. It is a cost-effective ...

Early diagnosis is vital for HIV. The sooner you receive a blood test and diagnosis, the sooner you can start treatment to bring and keep HIV at undetectable levels. Staying in close contact with ...

MANILA, Philippines – The number of newly diagnosed Advanced HIV Disease (AHD) cases in the country is increasing, the Department of Health (DOH) said Friday. The World Health Organization (WHO ...

supporting its value in HIV ARV medication adherence studies (Nieuwkerk and Oort 2005; Simoni et al. 2006). An obstacle to progress in the HIV ARV medication adherence field has been the absence ...